Outlook Therapeutics, Inc. (OTLK) › Operating IncomeOutlook Therapeutics, Inc. (OTLK) — Operating IncomeAnnual figures by period end, from SEC filings.2015-09-30: -$46.56M2016-09-30: -$51.35M2017-09-30: -$35.88M2018-09-30: -$29.64M2019-09-30: -$36.30M2020-09-30: -$36.84M2021-09-30: -$51.73M2022-09-30: -$63.07M2023-09-30: -$53.13M2024-09-30: -$71.70M2025-09-30: -$67.06M-$67.06M2015-09-30Operating Income (USD)2025-09-30Period endedOperating IncomeChange YoYSource filing2025-09-30-$67.06M—2025-12-19From 2024-10-012024-09-30-$71.70M—2025-12-19From 2023-10-012023-09-30-$53.13M—2024-12-27From 2022-10-012022-09-30-$63.07M—2023-12-22From 2021-10-012021-09-30-$51.73M—2022-12-29From 2020-10-012020-09-30-$36.84M—2021-12-23From 2019-10-012019-09-30-$36.30M—2020-12-23From 2018-10-012018-09-30-$29.64M—2019-12-19From 2017-10-012017-09-30-$35.88M—2018-12-18From 2016-10-012016-09-30-$51.35M—2017-12-29From 2015-10-012015-09-30-$46.56M—2016-12-29From 2014-10-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)